Apexigen, Inc.
APGNDelisted Aug 23, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001814140
Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Apexigen, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 17 | 0 | −17 |
| Shares | 3.19M | 0 | −3.19M (−100.0%) |
| Value | $1.37M | $0 | −$1.37M (−100.0%) |
New holders (0)
Institutions that held Apexigen, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (17)
Institutions that held Apexigen, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,894,551 | $814.3K |
| Fan Yu | 401,757 | $172.7K |
| Vanguard Group Inc | 256,935 | $110.4K |
| BlackRock Inc. | 213,833 | $91.9K |
| Geode Capital Management, LLC | 178,760 | $76.8K |
| State Street Corp | 54,300 | $23.3K |
| Mercer Global Advisors Inc | 43,626 | $19.0K |
| Renaissance Technologies LLC | 44,150 | $19.0K |
| Northern Trust Corp | 31,041 | $13.3K |
| Two Sigma Investments, LP | 17,006 | $7.31K |
| Two Sigma Securities, LLC | 14,233 | $6.12K |
| Destination Wealth Management | 13,216 | $5.68K |
| Tower Research Capital LLC (TRC) | 12,106 | $5.21K |
| JBF Capital, Inc. | 9,130 | $3.92K |
| Simplex Trading, LLC | 3,308 | $1.00K |
| Wells Fargo & Company | 154 | $66 |
| Cutler Group LP | 300 | $0 |